Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Pathology

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)64623-8PMID 11021812PMCID PMC1850182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues

  2004cited by this paper
• KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.

  2000cited by this paper
• Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.

  1999cited by this paper
• Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.

  1999cited by this paper
• Gastrointestinal stromal tumors: recent advances in understanding of their biology.

  1999cited by this paper
• C‐kit Gene Abnormalities in Gastrointestinal Stromal Tumors (Tumors of Interstitial Cells of Cajal)

  1999cited by this paper
• Activating c-kit gene mutations in human germ cell tumors.

  1999cited by this paper
• c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia

  1999cited by this paper
• Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors

  1999cited by this paper
• Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.

  1998cited by this paper
• Familial gastrointestinal stromal tumours with germline mutation of the KIT gene

  1998cited by this paper
• Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

  1998cited by this paper
• KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors.

  1998cited by this paper
• CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.

  1998cited by this paper
• The protooncogene c-kit and c-kit ligand in human disease.

  1997cited by this paper
• A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract.

  1996cited by this paper
• Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

  1995cited by this paper
• c‐kit point mutation of extracellular domain in patients with myeloproliferative disorders

  1995cited by this paper
• Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

  1993cited by this paper
• Requirement of c-kit for development of intestinal pacemaker system.

  1992cited by this paper
• Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor

  1990cited by this paper
• Identification of a ligand for the c-kit proto-oncogene.

  1990cited by this paper
• Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

  1987cited by this paper

• Molecular Profiling of KIT/PDGFRA-Mutant and Wild-Type Gastrointestinal Stromal Tumors (GISTs) with Clinicopathological Correlation: An 18-Year Experience at a Tertiary Center in Kuwait

  2024cites this paper
• Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors

  2024cites this paper
• Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.

  2024cites this paper
• KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment

  2022cites this paper
• A Gastroenterologist's Approach to the Diagnosis and Management of Gastrointestinal Stromal Tumors.

  2022cites this paper
• Molecular Pathogenesis of Gastrointestinal Stromal Tumor: A Paradigm for Personalized Medicine.

  2021cites this paper
• Mutation of KIT in cellular extraskeletal myxoid chondrosarcoma: a case report and literature review

  2021cites this paper
• Comparative Efficacy and Safety of Different Regimens of Advanced Gastrointestinal Stromal Tumors After Failure Prior Tyrosine Kinase Inhibitors: A Network Meta-Analysis

  2020cites this paper
• Identification of novel point mutations in c-kit gene from Leukemia cases: a study from Lucknow, Uttar Pradesh, India

  2020cites this paper
• Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review.

  2020cites this paper
• Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study

  2020cites this paper
• Analysis of C-Kit Exon 9, Exon 11 and BRAFV600E Mutations Using Sangers Sequencing in Gastrointestinal Stromal Tumours

  2020cites this paper
• New frontiers in the medical management of gastrointestinal stromal tumours

  2019cites this paper
• Outcomes After Surgical Resection Differ by Primary Tumor Location for Metastatic Gastrointestinal Stromal Tumors (GISTs): a Propensity Score Matching Population Study

  2018cites this paper
• Surgical resection for a giant gastrointestinal stromal tumor: A case report

  2018cites this paper
• Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients

  2018cites this paper
• The 100 Most Influential Papers and Recent Trends in the Field of Gastrointestinal Stromal Tumours: A Bibliometric Analysis

  2018cites this paper
• Two new KIT exon 13 mutations in one gastric gastrointestinal stromal tumor (GIST).

  2017cites this paper
• Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers*

  2017cites this paper
• Prognostic Factors for Advanced GIST

  2017cites this paper
• GEIS guidelines for gastrointestinal sarcomas (GIST).

  2017cites this paper
• Gastrointestinal Stromal Tumor: Genotype Frequency and Prognostic Relevance

  2016cites this paper
• Gastrointestinal Stromal Tumors

  2016cites this paper
• Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.

  2016cites this paper
• PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1

  2016cites this paper
• Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long?

  2015cites this paper
• Modélisation et analyse de l'hétérogénéité tumorale lors de résistance aux traitements : cas des métastases hépatiques de GIST

  2015cites this paper
• Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study

  2015cites this paper
• Novel R634W c‐kit Mutation Identified in Familial Mastocytosis

  2015cites this paper
• Analysis of mutation of the c-Kit gene and PDGFRA in gastrointestinal stromal tumors.

  2015cites this paper
• Targeted Therapy for Gastrointestinal Stromal Tumor : Emerging concepts in oncogenetics and therapy sequencing

  2015cites this paper
• miRNA‐221 and miRNA‐222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours

  2015cites this paper
• Targeted Therapy in Gastrointestinal Stromal Tumors

  2015cites this paper
• Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.

  2015cites this paper
• GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)

  2014cites this paper
• The Overexpression of KIT Proto-Oncogene in Acute Leukemic Cells Is Not Necessarily Caused by the Gene Mutation

  2014cites this paper
• Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.

  2014cites this paper
• Features of gastric glomus tumor: a clinicopathologic, immunohistochemical and molecular retrospective study.

  2014cites this paper
• Targeted therapies for sarcomas: new roles for the pathologist

  2014cites this paper
• Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors

  2013cites this paper
• Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.

  2013cites this paper
• A Hidden Source for Upper Gastrointestinal Bleeding

  2013cites this paper
• Core binding factor acute myeloid leukaemia and c-KIT mutations.

  2013cites this paper
• Biomarkers in GIST

  2013cites this paper
• Gastrointestinal Stromal Tumors: From Molecular Pathogenesis to Therapy

  2013cites this paper
• Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations: Update on Genotype-Phenotype Correlation and Validation of a High-Resolution Melting Assay for Mutational Testing

  2013cites this paper
• CASPASE-3 PROMOTES CELL PROLIFERATION AND INHIBITS DNA-DAMAGE INDUCED NECROSIS IN COLORECTAL CANCER

  2013cites this paper
• Molecular Biology and Pathology of Gastrointestinal Stromal Tumors

  2013cites this paper
• Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study

  2012cites this paper
• A STUDY OF OUTCOME OF METASTATIC GASTROINTESTINAL STROMAL TUMORS TREATED WITH IMATINIB AND CORRELATION WITH C-KIT MUTATION STATUS

  2012cites this paper
• The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia

  2012cites this paper
• Gastrointestinal mesenchymal tumors

  2012cites this paper
• Targeted therapies: how personal should we go?

  2012cites this paper
• Gene Signatures in Gastrointestinal Stromal Tumors

  2012cites this paper
• of gastrointestinal stromal tumor

  2012cites this paper
• High-Risk CD117-Positive Gastrointestinal Stromal Tumor of the Colon in a 12-Year-Old Girl: Adjuvant Treatment with Imatinib Mesylate

  2012cites this paper
• Imatinib resistance and microcytic erythrocytosis in a KitV558Δ;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor

  2012cites this paper
• Identificación de nuevas mutaciones puntuales en el gen c-kit en casos de Leucemia: un estudio realizado en Lucknow, Uttar Pradesh, India

  2012cites this paper
• MicroRNA involvement in gastrointestinal stromal tumor tumorigenesis.

  2012cites this paper
• Characterization of novel germline c-kit gene mutation, KIT-Tyr553Cys, observed in a family with multiple gastrointestinal stromal tumors

  2012cites this paper
• Modeling Oncogenic KIT Signaling and Drug Resistance in the Mouse

  2012cites this paper
• Synchronous and metachronous multiple gastrointestinal stromal tumors.

  2012cites this paper
• Mutationsbasierter Therapiealgorithmus bei gastrointestinalen Stromatumoren

  2012cites this paper
• Extra-gastrointestinal stromal tumor of the pelvic cavity: case report

  2012cites this paper
• Stromal Tumours of the Stomach

  2012cites this paper
• Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression

  2012cites this paper
• Agent thérapeutique pour les tumeurs

  2012cites this paper
• High-risk CD117-positive gastrointestinal stromal tumor of the colon in a 12-year-old girl: adjuvant treatment with imatinib mesylate.

  2012cites this paper
• Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome

  2012cites this paper
• Receptor tyrosine kinase kit and gastrointestinal stromal tumours: an overview.

  2011cites this paper
• C-kit proto-oncogene deletion and point mutation at exon 8 , 17 in human acute myeloid leukemia

  2011cites this paper
• Gastrointestinal Stromal Tumors: Molecular Mechanisms and Targeted Therapies

  2011cites this paper
• Gastrointestinal Stromal Tumours: A Contemporary Review on Pathogenesis, Morphology and Prognosis

  2011influential citation
• The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting

  2011cites this paper
• Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.

  2011cites this paper
• Guía de práctica clínica en los tumores estromales gastrointestinales (GIST): actualización 2010

  2011cites this paper
• Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour

  2011cites this paper
• Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).

  2011cites this paper
• Gene Mutations and Prognostic Factors Analysis in Extragastrointestinal Stromal Tumor of a Chinese Three-Center Study

  2011cites this paper
• KIT amplification and gene mutations in acral/mucosal melanoma in Korea

  2011cites this paper
• Targeted therapy for gastrointestinal stromal tumors: current status and future perspectives

  2010cites this paper
• Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors.

  2010cites this paper
• Valor de la expresión inmunohistoquímica de CD117 y del estudio molecular de c-KIT y PDGFRα en la redefinición diagnóstica de una serie retrospectiva de tumores mesenquimales del tracto gastrointestinal

  2010cites this paper
• Factores de sobrevida en 152 pacientes con tumores estromales gastrointestinales

  2010cites this paper
• Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone—An array comparative genomic hybridization study

  2010cites this paper
• Clinical implications of KIT and PDGFRA genotyping in GIST

  2010cites this paper
• KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors.

  2010cites this paper
• Imatinib mesylate for the treatment of gastrointestinal stromal tumor

  2010cites this paper
• MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site

  2010cites this paper
• Expresión Inmunohistoquímica de Vimentina, CD 34 y c-Kit (CD 117) en Tumores Estromales Gastrointestinales (GISTs)

  2010cites this paper
• Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors

  2010cites this paper
• Response to Moskaluk et al

  2010cites this paper
• Colorectal gastrointestinal stromal tumor

  2010cites this paper
• Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: comparison of DHPLC and DNA sequencing methods using a single population-based cohort.

  2010cites this paper
• Molecular Cancer esearch aling and Regulation tinib Upregulates Compensatory Integrin Signaling in a se Model of Gastrointestinal Stromal Tumor and Is More R ctive When Combined with Dasatinib

  2010cites this paper
• Imatinib Upregulates Compensatory Integrin Signaling in a Mouse Model of Gastrointestinal Stromal Tumor and Is More Effective When Combined with Dasatinib

  2010cites this paper
• Targeted therapies of gastrointestinal stromal tumors (GIST)--the next frontiers.

  2010cites this paper
• Current Clinical Pathology

  2010cites this paper
• Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.

  2009cites this paper
• Retroperitoneal and intra-abdominal sarcoma.

  2009cites this paper